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Abstract
Background: Clinical history-taking can be employed as a standardized approach to elucidate the use of herbal
medicines and their linked suspected adverse drug reactions (ADRs) among hospitalized patients. We sought to
identify herbal medicines nominated by Ugandan inpatients; compare nomination rates by ward and gender;
confirm the herbs’ known pharmacological properties from published literature; and identify ADRs linked to
pre-admission use of herbal medicines.
Methods: Prospective cohort of consented adult inpatients designed to assess medication use and ADRs on one
gynaecological and three medical wards of 1790-bed Mulago National Referral Hospital. Baseline and follow-up data
were obtained on patients’ characteristics, including pre-admission use of herbal medicines.
Results: Fourteen percent (26/191) of females in Gynaecology nominated at least one specific herbal medicine
compared with 20 % (114/571) of inpatients on medical wards [20 % (69/343) of females; 20 % (45/228) of males].
Frequent nominations were Persea americana (30), Mumbwa/multiple-herb clay rods (23), Aloe barbadensis (22), Beta
vulgaris (12), Vernonia amygdalina (11), Commelina africana (7), Bidens pilosa (7), Hoslundia opposita (6), Mangifera
indica (4), and Dicliptera laxata (4). Four inpatients experienced 10 suspected ADRs linked to pre-admission herbal
medicine use including Commelina africana (4), multiple-herb-mumbwa (1), or unspecified local-herbs (5): three
ADR-cases were abortion-related and one kidney-related.
Conclusions: The named herbal medicines and their nomination rates generally differed by specialized ward,
probably guided by local folklore knowledge of their use. Clinical elicitation from inpatients can generate valuable
safety data on herbal medicine use. However, larger routine studies might increase the utility of our method to
assess herbal medicine use and detect herb-linked ADRs. Future studies should take testable samples of
ADR-implicated herbal medicines for further analysis.
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Background
Over 60 % of conventional medicines on the global mar-
ket have been derived either directly or indirectly from
natural products, including herbs [1]. Alternative/herbal
medicines, hereafter herbal medicines, have a variety of
biological properties, among them the ability to contract
the uterus and thereby induce abortion and/or reduce
post-partum bleeding [2]. In Uganda, as in several other
African countries, inducing abortion is illegal unless the
physical or mental health of the mother is severely at-
risk [3, 4]. Women who seek an abortion may therefore
have recourse to the frequently unsafe traditional
methods to induce foetal loss [3]. Thus, incomplete
abortion or miscarriage is a key reason for admission to
gynaecological wards [5]. Outside of Uganda, such
admissions have been the focus of previous studies of
“unsafe abortion”: for example, in rural Tanzania, where
125 (67 %) of 187 women admitted with incomplete
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abortion, when interviewed empathetically, revealed that
they had experienced unsafe abortion prior to the
current admission [6]. Examples of plants used tradition-
ally to procure abortion, whose uterotonic properties
have been formally tested and confirmed, include: Bidens
pilosa L., Commelina africana L., Desmodium barbatum
(L.) Benth, Manihot esculenta Crantz, Ocimum suave
Klilld., Oldenlandia corymbosa L., and Vernonia amyg-
dalina Delile [3, 7]. The use of different plant parts and
solvents to obtain a plant’s extracts might account for
differences in the extracts’ biological properties. The
highest test concentration of an ethanolic root extract of
Bidens pilosa (1.40 mg/ml) decreased rat uterine con-
tractility below the level of spontaneous contractions
(i.e. was toxic to the uterine muscle) while a similar con-
centration (1.43 mg/ml) of an aqueous leaf extract of
Bidens pilosa increased uterine contractions [3, 8].
Other uses of herbs in folk medicine have been re-
ported, some being confirmed by formal testing of the
herbs’ pharmacological activity. For instance, Dicliptera
laxata is used by herbalists in Kenya to treat colorectal
cancer [9] and in Uganda as a poison antidote [10],
though no published literature was available to confirm
these claims. However, Dicliptera laxata has antimicrobial
[11], anti-inflammatory and antinociceptive properties
[12]; traditionally, its roots are chewed as a cough remedy
and for stomach pain while its leaf extract is drunk to treat
fever, headache, rashes and itching [11, 13].
Extracts of Bidens pilosa L are reported to have antihy-
perglycaemic, antihypertensive, antiulcerogenic, hepato-
protective, antipyretic, immunosuppressive and anti-
inflammatory, anti-leukemic, anti-malarial, anti-bacterial,
antioxidant, antitumour and antifungal effects [14–17].
Hoslundia opposita is used post-partum to cleanse the
uterus of any blood clots and heal vaginal lacerations after
childbirth. Pharmacological investigations indicate numer-
ous properties of Hoslundia opposita including antimicro-
bial, analgesic, anti-inflammatory, antimalarial, antidiabetic,
acaricidal and central nervous system activity [18–22].
Our research-team’s approach was only as empathetic
as clinical history-taking at its best but had the advan-
tage of being standardized: the same questions about
herbal medicine use in the 4-weeks prior to hospital ad-
mission were posed to representatively sampled patients
in three medical wards and one gynaecological ward.
Moreover, adverse event reporting for herbal medicines
[23] employed the existing routine clinical approach to
elucidate the safety of herbs without the need for sophis-
ticated and costly methods, or the use of the not well-
studied ethnopharmacovigilance concept [24]. Our study
aimed to identify the herbal medicines nominated by
Ugandan inpatients; compare the nomination rates by
ward and gender; confirm the herbs’ known pharmaco-
logical properties from published literature; and identify
suspected adverse drug reactions (ADRs) linked to pre-
admission use of herbal medicines.
Methods
Study design and setting
The study site was the 1790-bed Mulago National Referral
Hospital [25] which receives an annual inpatient turnover
of more than 140,000 patients. The study setting, design
and data collection/management have been described
elsewhere [26]. The study setting comprised three medical
wards [Infectious Diseases and Gastrointestinal Illnesses
(IDGI); Haematology, Neurology and Endocrinology
(HNE); Cardiovascular, Pulmonology and Nephrology
(CPN)] and one Gynaecological ward (GYN). Each of the
four wards has an official bed capacity of 54 but can
receive 70 to 80. Admissions on the medical wards aver-
age 10–15 patients per day in each of wards IDGI & CPN
and 5–10 patients per day in HNE, thus about 25–40
medical wards admissions per day; and 20–25 admissions
per day on the GYN ward.
Data collection
During October to November 2013, a pilot phase was
conducted on all four wards to assess the feasibility of
undertaking the cohort study and to refine study instru-
ments. The pilot data, however, are excluded from the
final analyses. The main study commenced in December
2013 to April 2014 when research teams recruited
patients on the study wards according to a systematic
random sampling procedure with three new admissions
per day on long-stay wards (HNE/CPN) and six per day
on short-stay wards (IDGI/GYN). Each ward-team pur-
posed to select at random one of the first two (IDGI),
three (HNE), and four (CPN/GYN) new admissions, and
subsequently every second, third, and fourth admission
respectively. Voluntary participation of the inpatients
(≥18 years) was sought through provision of written in-
formed consent.
On Day 1 of recruitment, we assessed medication use
and ADRs among the inpatients. Each ward’s research
team interviewed the patients and/or their caregivers to
obtain relevant baseline data on demographics, clinical
conditions, and medications including herbal medicines;
and subsequently conducted daily assessments until dis-
charge, transfer, death, or loss to follow-up. The elicited
information included details on the use of herbal medi-
cines in the 4-weeks prior to hospitalization and, where
possible, the specific names of these herbal remedies.
Patients who were coded as having used herbal medi-
cines in the 4-weeks prior to hospital admission but for
whom no herbal medicine was listed were counted as
not having taken a nominated herbal medicine. We pro-
vide sub-totals for these exclusions. Patients were
counted as having taken a nominated herbal medicine if
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they answered “no” to the lead-in question about hav-
ing taken herbal medicines in the previous 4-weeks,
yet they nominated herbal remedies they had taken at
admission or in the previous 4-weeks on a subsequent
form where questions on herbal medicines used were
posed as part of routine clinical elicitation of all med-
icines. For completeness, patients’ responses were
counted as “yes” even if their nomination was as
vague as “unknown liquid”.
First, we identified the herbal medicines nominated by
the women admitted to our study from the GYN ward at
Mulago Hospital. Nominations of herbal medicines were
then compared between the women admitted for abortion-
related reasons and: i) the recruited females admitted to
GYN for other reasons; ii) the females admitted to the
medical wards; and iii) the males recruited from the med-
ical wards. Next, we identified the Latin botanical names
for plant remedies which were frequently nominated by pa-
tients in our GYN ward or differentially nominated be-
tween patients in GYN and the three medical wards (using
a minimum of at least four nominations as our criterion
for selection). For the selected plants with linked Latin bo-
tanical name, we sought confirmation from the published
literature about their known pharmacological properties.
Lastly, we identified the suspected ADRs linked to the pre-
admission use of herbal medicines. A suspected ADR was
any undesirable medical occurrence that developed after
the administration of medicine and for which there was, at
least, a possible causal relationship between the medicine
and the event as measured by the Naranjo ADR Probability
Scale [27, 28]. Seriousness was assessed using the WHO
Uppsala Monitoring Centre (UMC) criteria [29]. Consen-
sus agreement on ADR causality and seriousness was done
in a committee headed by the ward-based study physician
and senior clinical pharmacist (principal author) [26].
Data analysis
Descriptive statistics on nomination-frequency are pre-
sented separately for the Gynaecological ward, female
inpatients in the three medical wards, and male inpatients
in the three medical wards; and for the inpatients in the
GYN ward according to whether (or not) their admission
was abortion-related. Posthoc comparison of nomination
rates by ward, gender and specific herbal medicine was
done using χ2 tests to assess statistical differences.
For the more frequently-nominated plant remedies for
which the Latin botanical name was ascertained and bio-
logical properties other than abortifacient were identified,
the clinical history of the associated patients – given by
working diagnoses - was summarized to discover if any of
the patients’ diagnoses or co-morbidities aligned with the
plant’s identified biological properties.
Results
Table 1 summarizes, by ward and gender, the available
information on herbal medicine use by 176 (79 %) of 222
inpatients who nominated at least one specific or vague
herbal medicine. One in seven of the female inpatients in
GYN (14 %, 26/191) nominated at least one specific herbal
remedy, as detailed in Table 2. By comparison, specific
nominations were made by 19 % (39/201) of females and
24 % (29/119) of males in the IDGI ward; by 31 % (22/72)
of females and 18 % (8/45) of males in HNE; and by 11 %
(8/70) of females and 12 % (8/64) of males in CPN. The
proportion of inpatients on CPN (37 %, 16/43) that speci-
fied the herbal medicine used was only half that in the
other two medical wards: IDGI at 73 % (68/93) and HNE
at 75 % (30/40). The specification rate of herbal medicines
on CPN was also lower than in the GYN which achieved
specific nominations by 57 % (26/46) of patients who gave
some indication of having used herbal medicines in the
4-weeks prior to admission. In summary, across the three
medical wards, specific nominations of at least one herbal
remedy used in the 4-weeks prior to, or at, admission were
made by 20 % (69/343) of females and by 20 % (45/228) of
males.
Table 2 documents the frequency of specific nominations
by inpatients on the study wards, provides Latin botanical
Table 1 Patients who nominated specific herbal medicines that they had used in the 4-weeks prior to hospital admission: by ward
and gender, Uganda, 2014
Herbal medicine use Ward and gender










Abortion-related + Other admissions Female Male Female Male Female Male
No declared use in the past four weeks 61 + 84 = 145 145 82 44 33 46 45
Coded yes, but no details 7 + 5 = 12 8 5 6 1 11 3
Only vague nominations of remedies used 5 + 3 = 8 9 3 0 3 5 8
At least one specific remedy nominated 11 + 15 = 26 39 29 22 8 8 8
Totals 107 + 84 = 191 201 119 72 45 70 64
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names, and for the most frequently nominated, provides
commentary on their pharmacological activity and local
folklore knowledge. On the GYN ward, Mumbwa (clay
rod) received 13 citations followed by Nanda (Commelina
africana) and Kamunye (Hoslundia opposita) which
received four mentions each, see also Additional file 1:
Table S1. On the three medical wards (IDGI, HNE, CPN),
frequent nominations were of avocado leaves (28), aloe
vera (22), beet root (12), mululuza (11), and mumbwa (10).
Twenty-six (31 %) of the 83 female inpatients on the med-
ical wards who made specific or vague nominations
reported at least two nominations, as did 20 % (12/59) of
male-nominators.
Mululuza (Vernonia amygdalina) had 11 mentions
overall, none from the GYN ward. Furthermore, Nanda
(Commelina africana) and Sere (Bidens pilosa) each had
seven mentions, Kamunye (Hoslundia opposita) had six
mentions and Muzukizi (Dicliptere Laxata) had four
mentions, see Table 2. Just below this threshold was
Kazire (proprietary herbal concoction which contains
mainly aloe vera) with three mentions, see Additional
file 1: Table S2.
Nanda’s nominations by seven inpatients included two
males from CPN whose working diagnoses were: i) newly
diagnosed with immunosupressed syndrome (ISS) and acute
gastroenteritis, oral candidiasis and lymphoma; and ii) com-
munity-acquired pneumonia with pulmonary tuberculosis.
Kamunye’s six nominations included two patients in
CPN, one of them male, whose clinical histories were:
i) male with pulmonary tuberculosis and ISS; and ii) female
with hypertensive heart disease in failure, and severe
hypertension.
Mululuza was not cited by any of the 191 female patients
on GYN (versus 2.8 expected) but 11 mentions were made
by 571 patients in medical wards (versus 8.2 expected), a
marginally statistically significant posthoc comparison.
Eight of Mululuza’s 11 mentions were from the 320 inpa-
tients in IDGI.
Table 2 Specific herbal medicines nominated by 176 out of 762 hospitalized patients at Mulago Hospital, Uganda, 2014
Traditional herbal medicine No. of citations Commentary
Local name Botanical name GYN (N = 191) Medical Wards














1 1 17 11 30 Local knowledge: Used mainly in patients with
anaemia to raise their haemoglobin levels
Mumbwa – 6 7 5 5 23 Local knowledge: multiple herb-containing clay
rods administered orally. Assumed to serve as
wellbeing supplement for the foetus and mother.
Kigagi (Aloe vera) Aloe
barbadensis
0 0 12 10 22 Treats fever
Beet root Beta vulgaris 0 0 7 5 12 For treatment of anaemia
Mululuza Vernonia
amygdalina
0 0 6 5 11 Local knowledge: Treats fever, malaria
Nanda Commelina
africana
2 2 1 2 7 Local knowledge: Induces abortion. Inserted
adjacent to the cervix to induce it to dilate.
Literature: Hypoglycaemic properties
Sere (Blackjack) Bidens pilosa 1 0 4 2 7 Wide range of biological properties including
significant antibacterial and antifungal activity
Kamunye Hoslundia
opposita
3 1 1 1 6 Locally: Cleanses uterus, treats vaginal lacerations
after childbirth and fever.





0 0 4 0 4 For anaemia




1 0 0 0 1 None of these three herbs was mentioned by
any of the inpatients on the IDGI, HNE and CPN
wards.
Local knowledge: Kiyondo is aphrodisiac
Literature: Kiyondo - anticonvulsant, antidiabetic
and wound healing.




1 0 0 0 1
Ekigaranga 1 0 0 0 1
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Sere (Biden pilosa) was mentioned in all four wards
and by both sexes (five females; two males), see
Additional file 1: Table S3 for their diverse clinical his-
tories and for those of four patients who nominated
Musukizi (Dicliptera laxata).
Three herbal remedies were each nominated once by
the 107 abortion-related patients in GYN but not once
by any of the 343 females or by any of the 228 male pa-
tients on the medical wards. This may be happenstance.
Nonetheless, we tried to establish the botanical names
for Ekigaranga, Gwalimu (also called Naligwalimu), and
Kiyondo (also called Ekiyondo) in order to investigate
their published properties (if any); and were successful
for Kiyondo (Kalanchoe pinnata Lam), which has anti-
convulsant, antidiabetic and wound healing properties
and Gwalimu [Maytenus senegalensis (Lam) Exell] with
antibacterial and anti-inflammatory activity, see Table 2
& Additional file 1: Table S1.
Finally, Table 3 shows the suspected ADRs linked to
the pre-admission use of herbal medicines: 10 suspected
ADRs were experienced by four patients, three of whom
were from GYN and one from CPN. Except for vaginally
inserted Nanda (Commelina africana) stick, all the other
ADR-implicated herbal remedies were administered
orally.
Discussion
Frequency of nominated herbal medicines by ward and
gender
The specific herbal medicines nominated by inpatients
on the various specialized wards generally differed, prob-
ably guided by local folklore knowledge of their use.
Mumbwa, which are clay rods constituted with one or
more local herbs, received the highest number of cita-
tions on the Gynaecological ward (GYN); however, pa-
tients were seldom aware of the specific herbs that were
compounded in these clay rods. Nanda (Commelina
africana) was the next most frequently cited herb on
GYN and is known to contract the uterus [7]. Comme-
lina africana is normally administered orally; however, it
was inserted vaginally as a stick by one woman admitted
on GYN who poked her cervix/uterus to induce abor-
tion. Kamunye (Hoslundia opposita) was another
commonly nominated herb which, according to local ob-
stetricians, is traditionally used post-partum to cleanse
the uterus of any blood clots and heal the vaginal lacera-
tions caused by childbirth. Hoslundia opposita is re-
ported in the literature to have anti-inflammatory (linked
to saponin-content) and wound healing (linked to
coumarin-content) properties [30, 31], which is consistent
with Hoslundia opposita’s local use for gynaecological con-
ditions, as mentioned above. Sere (Bidens pilosa), was used
on all four wards and by both males and females. Sere is
reported, in folk medicine, to treat various disease condi-
tions, which is attributed to its varied biological activity
including antibacterial, antifungal, anti-inflammatory, anti-
pyretic, antimalarial, antihyperglycaemic, antihypertensive,
hepatoprotective, antiulcerogenic, and anticancer proper-
ties, among others [14–16].
The specific nomination rate of herbal medicines was
lowest on the CPN ward when compared with the other
wards; however there was no difference in nomination
rate by gender. Mumbwa received a noticeable and com-
parable number of citations on the three medical wards
vs. the GYN ward. However, avocado leaves (Persea
americana), aloe vera (Aloe barbadensis), beet root (Beta
Table 3 Suspected ADRs linked to the use of herbal medicines in the 4-weeks prior to hospital admission
Pt No. Herbal medicine Suspected ADR Serious Causality Ward Working diagnosis
Experienced herbal medicine-related suspected ADRs only
1. Mumbwa Abdominal pain with associated
contractions
Yes Probable GYN Complete abortion, Urinary tract infection, Inevitable
abortion
2.a) Nanda stick Vaginal bleeding No Possible GYN Septic abortion
Dysuria Yes Possible
2.b) Local herbs Diarrhoea Yes Possible
Lower abdominal pain Yes Possible
Experienced other non-herbal medicine-related suspected ADRs
3. Nanda Bloody vomitus Yes Possible GYN Missed abortion, gastrointestinal infection
Bloody diarrhoea Yes Possible
4. Unknown liquid Hyponatremia Yes Possible CPN Acute kidney injury secondary to toxins from herb,
glomerular nephritis, severe anaemia
Abdominal distension No Possible
Anaemiaa Yes Possible
Source of herbal medicines: patient no. 1 - Auntie; patient no. 2 - sister, patient no. 3 - self-medication, and patient no. 4 - traditional herbalist. Except for vaginally
inserted nanda stick, all other herbal remedies were taken orally
aADR causation was also linked to ceftriaxone and/or captopril use
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vulgaris), mululuza (Vernonia amygdalina), and muzu-
kizi (Dicliptera laxata) were predominantly cited on the
medical wards. Avocado leaves and beet root are used
for anaemia. Commelina africana was mentioned with
similar frequencies on both the medical and gynaeco-
logical wards. In addition to its uterotonic properties,
Commelina africana is reported to have hypoglycaemic
effects [32]. Vernonia amygdalina is used traditionally to
treat malaria: and the herb’s antimalarial activity has
been validated [33]. Dicliptera laxata is used by herbal-
ists in Kenya to treat colorectal cancer [9] and as anti-
dote to poison in Uganda [10]: however, studies to
document the anticancer and poison antidote properties
of this herb are scarce. Dicliptera laxata is reported to
have antimicrobial, anti-inflammatory and antinocicep-
tive properties, with its leaves being used to treat rashes
and itching [11, 12]: the herb is also used to treat head-
ache in Ethiopia [13].
Among the three herbs nominated on the GYN ward
but not on the three medical wards, Kiyondo (Kalanchoe
pinnata Lam) in local Ugandan folklore knowledge is
used to dry a newborn’s umbilical cord [34], treat morn-
ing sickness in pregnant women and also has aphrodis-
iac properties. Kalanchoe pinnata Lam is proven to have
anticonvulsant, antidiabetic and wound healing proper-
ties [35–37]. Gwalimu [Maytenus senegalensis (Lam.)
Excell] is used locally to treat infections and inflammatory
conditions; and has been demonstrated to have antibacter-
ial and anti-inflammatory properties [38]. Gwalimu is also
used traditionally to treat fertility-related problems.
Published information and local folklore knowledge on
Ekigaranga was scarce.
We focused on the GYN herbals to identify “new”
abortifacients but this did not succeed. However, we
highlighted known abortifacients. We also compared
GYN versus the medical wards nomination rates (and
also by gender) to identify herbals with other active prin-
ciples, which worked insofar as those identified are
already known. The methodological approach used, we
believe, was sound although we clearly needed more
than 762 cases to make “discoveries”. Furthermore,
patients ought to specify the herbal remedies they have
taken, which they usually consume to complement
conventional western medication. Out of fear, though,
the patients may deliberately conceal the required infor-
mation on herbal medicine use [39]. Thus, the inquiry
skills of the clinical assessment teams should improve,
especially on the CPN ward, to increase the chances of
eliciting, from the patients, specific information on
herbal medicine use.
A considerable proportion of women on GYN (56 %,
107/191) presented with abortion-related diagnoses,
which is comparable with the proportion of Tanzanian
women (67 %, 125/187) with incomplete abortions who
conceded having had unsafe abortion prior to their
current hospitalization [6]. Half the Tanzanian women
had resorted to traditional providers and, in these cases,
plant species were often used as abortion remedies.
However, only one in five Ugandan inpatients with
abortion-related diagnoses reported having used herbal
medicines in the 4-weeks prior to hospital admission.
The annual global estimate of unsafe abortions in
women of reproductive age (15–44 years) is 14 per 1000
women and is higher in sub-Saharan Africa (31 per
1000) than in Eastern Europe (6 per 1000) [40]. In
addition, the abortion-attributable proportion of mater-
nal mortality is higher in Eastern Africa (18 %) than in
Eastern Europe (11 %), probably because abortion is
illegal in Eastern Africa [41].
Community-acquired suspected ADRs linked to pre-
admission use of herbal medicines
No serious suspected ADR was linked definitively to
herbal medicine use. Three of the four suspected ADRs
that implicated herbal medicine use occurred in patients
with abortion-related working diagnoses, in two of
whom the intention to abort was explicit. However, the
one case of acute kidney injury linked to herbal medi-
cine use in the community might not have been deliber-
ate. Unsafe use of herbal medicines to induce abortions
can lead to a high burden of overt preventable ADRs:
this information may be relatively easier to elicit clinically
from patients. However, it is the more subtle preventable
ADRs from herbs when used for other therapeutic pur-
poses which, in the absence of appropriate laboratory sup-
port and expertise in clinical diagnosis, might be difficult
to link to herbal medicine use and could thus go un-
noticed but silently continue to harm patients.
Four in five patients who reported use of herbal medi-
cines during the 4-weeks prior to admission nominated
at least one specific or vague herbal medicine during
routine clinical elicitation of all medicines. Clinical elicit-
ation is therefore a powerful tool for clinicians to obtain,
from patients, useful medication history of both herbal
and conventional western medicines to better conduct
medicines reconciliation and subsequently provide ap-
propriate pharmaceutical care to inpatients. Concurrent
use of conventional and herbal medicines, more so in
the community where there is little supervision, may
promote herb-drug interactions and increase the risk of
ADRs [42]. Overall, four patients (2 %, 4/222), or one in
50, experienced at least one community-acquired sus-
pected ADR linked to pre-admission use of a herbal
remedy signalling a relatively frequent occurrence of
patient-reported suspected ADRs linked to pre-
admission herbal remedies. Excluding abortion-related
suspected ADRs, only one patient in 222 (0.5 %) who
coded yes for the use of herbal remedies might have
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experienced an unintentional community-acquired sus-
pected ADR. Further investigation of the latter rate of 5
per 1000 patients requires a much larger, preferably rou-
tine PV system with integrated patient-reporting, and/or
pharmacoepidemiological studies to track and assess the
safety of herbal remedies used by patients. The patient-
reported suspected ADR estimates, however, cannot be
generalized to the wider community since the herb-
linked suspected ADRs themselves and/or failure by the
patients to have sought conventional treatment may
have provoked admission. However, a herb-linked ADR
estimate of ~5 per 1000 inpatients is sufficiently high for
ward staff to pay heed to. We did not take from patients
specimens of the consumed herbal medicines and, in some
instances, not even the herb constituents could be inferred,
which is a limitation. Hospital clinicians need routinely to
ask about and periodically obtain, for formal testing, sam-
ples of herbal remedies taken by the one in 50 patients with
a herb-linked suspected ADR, which might increase the
ability to identify definite ADRs. Caution is advised as the
low occurrence rate of reported unintentional herbal
medicine-linked ADRs may be due to non-disclosure by
the patients [39]. That limitation notwithstanding, our sys-
tems need to streamline ADR reporting for conventional
medicines before the safety monitoring of herbal medicines
can become a genuine reality.
Using logistic regression, our team previously con-
structed risk-scores for developing a suspected hospital-
acquired ADR for which one of the key covariates was
pre-admission use of herbal medicines. Those who had
used herbal medicines during the 4-weeks prior hospital
admission rarely specified the herbs they had taken [43].
A possible explanation for the failure by patients to spe-
cify their herbal medicines may be unlabelled herbal for-
mulations with concoctions/mixtures of several different
herbs that patients could not themselves identify [39]. If
so, might the multiple herbs per concoction/mixture,
when taken by the patient, have led to a higher likeli-
hood of herb-drug interactions in the hospitalized pa-
tients? Future surveillance should ensure that specimens
of the herbs taken by patients with linked suspected
ADRs are obtained and tested.
Conclusions
The named herbal medicines and their nomination rates
generally differed by specialized ward, probably guided by
local folklore knowledge of their use. Clinical elicitation
from inpatients can generate valuable safety data on
herbal medicine use. However, larger routine studies
might increase the utility of our method to assess herbal
medicine use and detect herb-linked ADRs. Future studies
should take testable samples of ADR-implicated herbal
medicines for further analysis.
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